These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37084132)

  • 1. Isosorbide DiNitrate Effect on Hemodynamic Profile, Liver Stiffness, and Exercise Tolerance in Fontan Circulation (The NEET Clinical Trial).
    Bigelow AM; Riggs KW; Morales DLS; Opotowsky AR; Lubert AM; Dillman JR; Veldtman GR; Heydarian HC; Trout AT; Cooper DS; Goldstein SL; Chin C; Palermo JJ; Ollberding NJ; Mays WA; Alsaied T
    Pediatr Cardiol; 2024 Oct; 45(7):1389-1397. PubMed ID: 37084132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.
    Zamani P; Akers S; Soto-Calderon H; Beraun M; Koppula MR; Varakantam S; Rawat D; Shiva-Kumar P; Haines PG; Chittams J; Townsend RR; Witschey WR; Segers P; Chirinos JA
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to changing plasma concentrations of isosorbide-bound NO2 during acute and sustained treatment with isosorbide dinitrate in patients with coronary artery disease.
    Jørgensen LH; Thaulow E; Bredesen J; Refsum HE
    Clin Cardiol; 2000 Jun; 23(6):427-32. PubMed ID: 10875033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End-Organ Function and Exercise Performance in Patients With Fontan Circulation: What Characterizes the High Performers?
    Weinreb SJ; Dodds KM; Burstein DS; Huang J; Rand EB; Mancilla E; Heimall JR; McBride MG; Paridon SM; Goldberg DJ; Rychik J
    J Am Heart Assoc; 2020 Dec; 9(24):e016850. PubMed ID: 33317366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of isosorbide dinitrate on electrocardiography, hemodynamics, and ventilation in patients with exercise-induced elevation of pulmonary artery wedge pressure.
    Jørgensen LH; Thaulow E; Refsum HE
    Clin Cardiol; 1999 Oct; 22(10):623-8. PubMed ID: 10526685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and Clinical Implications of Impaired Pulmonary Vascular Reserve in the Fontan Circulation.
    Egbe AC; Miranda WR; Anderson JH; Borlaug BA
    J Am Coll Cardiol; 2020 Dec; 76(23):2755-2763. PubMed ID: 33272370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind randomized multicenter study on the efficacy of trapidil versus isosorbide dinitrate in stable angina pectoris.
    Raubach KH; Vlahov V; Wolter K; Bussmann WD
    Clin Cardiol; 1997 May; 20(5):483-8. PubMed ID: 9134282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early hemodynamic effects at rest with acute and chronic isosorbide dinitrate treatment in patients with ischemic heart disease.
    Jørgensen LH; Thaulow E; Refsum HE
    Clin Cardiol; 1995 Aug; 18(8):455-9. PubMed ID: 7586763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic time course of acute and chronic isosorbide dinitrate treatment at rest and during exercise in patients with stable ischemic heart disease.
    Jørgensen LH; Thaulow E; Refsum HE
    Clin Cardiol; 1996 Sep; 19(9):718-24. PubMed ID: 8874991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrate tolerance: hemodynamic effects of intravenous isosorbide dinitrate after sustained oral isosorbide dinitrate administration.
    Kumagae H; Koiwaya Y; Tanaka K
    Clin Ther; 1990; 12(1):31-43. PubMed ID: 2328526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary vasodilators and exercise in Fontan circulation: a systematic review and meta-analysis.
    Kosmidis D; Arvanitaki A; Farmakis IT; Liakos A; Giannopoulos A; Ziakas A; Giannakoulas G
    Heart; 2024 Mar; 110(8):552-559. PubMed ID: 37918902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of molsidomine, isosorbide dinitrate, and nifedipine at rest and during exercise.
    Schartl M; Dougherty C; Rutsch W; Schmutzler H
    Am Heart J; 1985 Mar; 109(3 Pt 2):649-53. PubMed ID: 3838401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trapidil is as effective as isosorbide-dinitrate for treating stable angina pectoris: a multinational, multicenter, double-blind, randomized study.
    Meinertz T; Lehmacher W;
    Clin Res Cardiol; 2006 Apr; 95(4):217-23. PubMed ID: 16598591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of glyceryl trinitrate on venous and arterial effects of chronic, asymmetric isosorbide dinitrate treatment in patients with ischemic heart disease.
    Jørgensen LH; Refsum HE; Thaulow E
    Clin Cardiol; 1994 Feb; 17(2):65-70. PubMed ID: 8162628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of systemic venous return, pulmonary vascular resistance, and diastolic dysfunction to exercise capacity in patients with single ventricle receiving fontan palliation.
    Goldstein BH; Connor CE; Gooding L; Rocchini AP
    Am J Cardiol; 2010 Apr; 105(8):1169-75. PubMed ID: 20381672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure.
    Elkayam U; Roth A; Mehra A; Ostrzega E; Shotan A; Kulick D; Jamison M; Johnston JV; Rahimtoola SH
    Circulation; 1991 Nov; 84(5):2040-8. PubMed ID: 1934379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) study.
    Hebert A; Mikkelsen UR; Thilen U; Idorn L; Jensen AS; Nagy E; Hanseus K; Sørensen KE; Søndergaard L
    Circulation; 2014 Dec; 130(23):2021-30. PubMed ID: 25446057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual isosorbide dinitrate for the detection of obstruction in hypertrophic cardiomyopathy.
    Zemánek D; Tomasov P; Homolová S; Linhartová K; Veselka J
    Eur J Echocardiogr; 2011 Sep; 12(9):684-7. PubMed ID: 21821607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of isosorbide dinitrate in patients with congestive cardiac failure at rest and during submaximal supine exercise.
    Stephens JD; Camm AJ; Spurrell RA
    Arch Mal Coeur Vaiss; 1978 Mar; 71(3):241-50. PubMed ID: 416797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the time to onset of action on myocardial ischaemia following intravenous administration of isosorbide dinitrate and 5-isosorbide mononitrate in Chinese patients.
    Wu ZG; Li JN; Fan M; Shang YK; Zhang YW; Bai J; Ding R; Cheng JM; Liang C
    Arzneimittelforschung; 2004; 54(5):275-9. PubMed ID: 15212189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.